Protease inhibitor-associated angiolipomatosis

Journal of the American Academy of Dermatology

Volumn 42, Issue 1 I, 2000, Pages 129-131

  Dank, Jan P ^a   Colven, Roy ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; PROTEINASE INHIBITOR;

ADULT; ANGIOLIPOMA; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPOMATOSIS; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VIRUS INFECTION;

EID: 0033911869     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90021-5     Document Type: Article

References (7)

1. Hengel RL, Watts NB, Lennox JL. Benign symmetric lipomatosis associated with protease inhibitors [letter]. Lancet 1997;350: 1596.
2. Miller KD, Jones E, Yandovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871-5.
3. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F5-F58.
4. Herry I, Bernard L, de Truchis P, Perrone C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997;25:937-8.
5. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998;352:1881-3.
6. Allen PW. Recent advances in tumors of adipose tissue. Curr Top Pathol 1995;89:215-39.
7. Sciot R, Akerman M, Dal Cin P, Wever ID, Fletcher CDM, Mandahl N, et al. Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas. Am J Surg Pathol 1997;21:441-4.